提炼
结核病(TB)仍然是全球健康的重要问题,尽管它可以通过负担得起的治疗方法可以治愈,并且可用于诊断和通知的结核病患者。如果未正确给药,结核病治疗方案可能无法提供无复发的治疗,有利于持续传播和耐药性的出现。因此,监测结核病治疗的有效性在临床实践和监视中至关重要,以最大程度地提高患者护理的质量和公共卫生行动的有效性。标准化的结核病治疗结果定义已成为世界卫生组织(WHO)政策和国家结核病监视系统多年的特征。这允许随着时间的推移在国家和全球范围内监测结核病治疗结果。
抽象的
In 2021, WHO revised its tuberculosis treatment outcome definitions, making them uniformly applicable for different lengths of treatment for both drug-susceptible and drug-resistant diseasehttps://bit.ly/3jFFgOu
Acknowledgements
We would like to acknowledge and thank the two co-chairs of this meeting, Charles Daley and Cathy Hewison, as well as the numerous experts who attended the meeting and who contributed to the discussions. The meeting participants were: Carole Mitnick, Christoph Lange, Giovanni Battista Migliori, Mario Raviglione, Jonathon Campbell, Hoang Thanh Thuy, Maria Rodriguez, Welile Sikhondze, Norbert Ndjeka, Anastasia Samoilova, Yuhong Liu, Kuldeep Sachdeva, Daniele Maria Pelissari, Andrei Mosneaga, Sreenivas Nair, Morten Ruhwald, Fraser Wares, Grania Brigden, Draurio Barreira, Mohammed Yassin, Marlena Kaczmarek, Mukadi Ya Diul, Dumitru Chesov, Chen Yuan Chiang, James Seddon, Tony Garcia-Prats, Daniela Cirillo, Harald Hoffman, Sarabjit Chadha, Dissou Affolabi, Thandar Hmun, Renzong Li, Sabira Tahseen, Amir Khan, Choub Sok Chamreun, Nino Lomtadze, Mon Basilio, Dan Everitt and Xia Hui. In addition, we thank the WHO staff who attended this meeting: Tauhid Islam, Mukta Sharma, Vineet Bhatia, Askar Yedilbayev, Rafael Lopez Olarte, Kenza Bennani, Michel Gasana, Jean Louis Abena, Kyung Oh, Ernesto Jaramillo, Anna Dean, Marek Lalli, Marie-Christine Bartens, Charalampos Sismannidis and Olga Tosas-Auguet.
脚注
All authors are staff members of the World Health Organization (WHO). They alone are responsible for the views expressed in this publication and they do not necessarily represent the decisions or policies of WHO. The designations used and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of WHO concerning the legal status of any country, territory, city or area, or of its authorities, nor concerning the delimitation of its frontiers or boundaries.
利益冲突:N.N。Linh没有什么可披露的。
矛盾的我nterest: K. Viney has nothing to disclose.
利益冲突:Gegia M.没有什么可披露的。
矛盾的我nterest: D. Falzon has nothing to disclose.
矛盾的我nterest: P. Glaziou has nothing to disclose.
利益冲突:K。Floyd无话可说。
利益冲突:H。Timimi没有什么可披露的。
矛盾的我nterest: N. Ismail has nothing to disclose.
利益冲突:Zignol M.无需披露。
利益冲突:T。Kasaeva没有什么可披露的。
矛盾的我nterest: F. Mirzayev has nothing to disclose.
- 已收到2021年3月18日。
- AcceptedJune 30, 2021.
- 版权所有©作者2021。用于复制权和权限联系权限{at} ersnet.org